Features

Blueprint and Alexion team up on rare genetic disease

Blueprint Medicines has announced a strategic collaboration with Alexion to discover, develop and commercialise novel drug candidates for an undisclosed activated kinase target, which is the cause of a rare genetic disease. more »

Mar 3, 2015 2:25 PM News

Cell therapy maker open for business

Cell Medica, a cellular immunotherapy company, has started commercial cell therapy manufacturing at its facility at the Max-Delbrück-Center of Molecular Medicine in Berlin-Buch, Germany. more »

Feb 23, 2015 2:44 PM News

UK pharma in multi-million pound partnership with India

The UK Medical Research Council (MRC) and the Government of India Department for Biotechnology (DBT), have joined forces to fund three major global research centres. more »

News

From the show floor: Baltimore Innovations' Pharmapack debut

As Baltimore Innovations makes its Pharmapack Europe debut this week, EPM looks at what it's bringing to the local market. more »

Feb 11, 2015 1:00 PM News

Medical Expo
Built with Metro Publisher™